Quotient Limited logo
Quotient Limited Announces Positive Serological Disease Screening Results and Provides MosaiQ™ Development Program Update
11 janv. 2016 07h01 HE | Quotient Limited
JERSEY, Channel Islands, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, will present the following update on the MosaiQ™ development...
Quotient Limited logo
Quotient Limited to Expand Capability of Its MosaiQ™ Next-Generation Transfusion Diagnostics Platform to Include Nucleic Acid Testing
11 janv. 2016 07h00 HE | Quotient Limited
Initial feasibility study demonstrates ability to detect nucleic acid using MosaiQTMPotential for a single unified platform to perform blood grouping along with serological and molecular disease...
Quotient Limited logo
Quotient Limited to Participate in J.P. Morgan 2016 Healthcare Conference
22 déc. 2015 14h00 HE | Quotient Limited
JERSEY, Channel Islands, Dec. 22, 2015 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the company’s Chairman and Chief Executive...